IP Verse

Photosensitizing Antibody-Fluorophore Conjugates - EP2731626

The patent EP2731626 was granted to The United States OF America on Dec 19, 2018. The application was originally filed on Jun 27, 2012 under application number EP12738664A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2731626

THE UNITED STATES OF AMERICA
Application Number
EP12738664A
Filing Date
Jun 27, 2012
Status
Opposition Rejected
Jul 9, 2021
Publication Date
Dec 19, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANSep 18, 2019POTTER CLARKSON -

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5530020
DESCRIPTIONUS5585089
DESCRIPTIONUS5912264
DESCRIPTIONUS6610860
DESCRIPTIONWO2004018478
INTERNATIONAL-SEARCH-REPORTDE19717904
INTERNATIONAL-SEARCH-REPORTUS2012010558
INTERNATIONAL-SEARCH-REPORTWO03011106
INTERNATIONAL-SEARCH-REPORTWO03083811
INTERNATIONAL-SEARCH-REPORTWO2006092598
INTERNATIONAL-SEARCH-REPORTWO2008120134
INTERNATIONAL-SEARCH-REPORTWO2010085651
OPPOSITIONUS2012010558

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- CARCENAC M. et al., "Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates M", Br. J. Cancer, (20011127), vol. 85, no. 11, pages 1787 - 1793, XP002344230
OPPOSITION- SNYDER John W. et al., "Photodynamic Therapy: A l\rleans to Enhanced Drug Delivery to Tumors", Cancer Res., (20031201), vol. 63, no. 23, pages 8126 - 8131, XP055643533
OPPOSITION- WESSELS et al., "Advances in Cellular, Subcellular, and Nanoscale Imaging In Vitro and In Vivo", Cytometry A, (20100000), vol. 77, no. 7, pages 667 - 676, XP055643547
OPPOSITION- MITSUNAGA et al., "Near-Infrared Theranostic Photoimmunothery (PIT): Repeated Exposure of Light Enhances the effect of Immunoconjugate", Nat. Med., (20110227), vol. 17, no. 12, pages 1685 - 1691, XP002683827
OPPOSITION- GREISH K., "Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines", J. Drug Target., (20070000), vol. 15, no. 7-8, pages 457 - 464, XP055643499
OPPOSITION- CHEN et al., "Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications", Clin. Cancer Res., (20060200), vol. 12, no. 3, pages 917 - 923, XP055643506
OPPOSITION- WAITE C. L. et al., "Nanoscale Drug Delivery Systems for Enhanced Drug Penetration into Solid Tumors: Current Progress and Opportunities", Crit. Rev. Biomed. Eng., (20120000), vol. 40, no. 1, pages 21 - 41, XP055643542

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents